Chemsex and HIV treatment with long-acting injections
Part of Infections clinical trials.
This study tests if a long-acting HIV treatment shot, called Cabenuva, works well for people who use drugs like methamphetamine or GHB during sex. It may help make treatment easier for those who find daily pills challenging.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were assigned male at birth and are a man, trans-woman, or gender diverse person over 18.
- You use certain drugs (like meth, GHB, ketamine, or mephedrone) during sex at least once in the last month.
- You are living with HIV and your viral load is undetectable (below 50 copies/mL) on a stable daily pill regimen for at least one month.
- You are not currently seeing a therapist or counselor for support (no sessions in the last 3 months).
- You are not allergic or resistant to the medications in the study shot (cabotegravir or rilpivirine).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study offers a new injectable medication called lenacapavir to prevent HIV. It is for people who are HIV-negative and sexually active, and want to try a long-acting injection instead of daily pills.
This study tests a smartphone program to help HIV-negative men who have sex with men reduce meth use and improve PrEP adherence. It explores whether combining support for both behaviors is more effective than addressing them separately.
This study gives HIV-positive people who are doing well on HIV medication a small dose of methamphetamine to see how it affects their virus and immune system. Researchers want to understand if methamphetamine can wake up hidden HIV that's not being detected.
This study tests an investigational long-acting shot (MK-8527) to prevent HIV. It is for HIV-negative people who are at higher risk through anal sex without condoms, and who have not used other long-acting HIV prevention before.
This trial tests if switching to a long-acting injectable medication can help people with HIV who have trouble keeping their virus suppressed with daily pills. You would receive shots in the buttocks every few months instead of taking pills every day.
This study tests a new long-acting medicine that may help prevent HIV. It is given as an injection, and the study checks how safe it is and how it works in healthy volunteers.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.